Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
Sales | 68 | 20 | 0 | 11 | 683 |
Cost of Goods | 31 | 26 | N/A | 30 | 104 |
Gross Profit | 37 | -6 | N/A | -19 | 579 |
Operating Expenses | 2,244 | 2,084 | -1,492 | 1,954 | 2,377 |
Operating Income | -2,176 | -2,064 | 405 | -1,943 | -1,694 |
Interest Expense | 412 | 320 | 325 | 317 | 324 |
Other Income | 35 | 33 | -2,207 | 54 | 2,334 |
Pre-tax Income | -2,553 | -2,351 | -2,127 | -2,206 | 316 |
Net Income Continuous | -2,553 | -2,351 | -2,127 | -2,206 | 316 |
Net Income | $-2,553 | $-2,351 | $-2,634 | $-2,206 | $316 |
EPS Basic Total Ops | -1,062.50 | -1,062.50 | -1,187.50 | -1,062.50 | 125.00 |
EPS Basic Continuous Ops | -1,032.77 | -1,034.77 | -970.24 | -1,037.59 | 149.41 |
EPS Diluted Total Ops | -1,062.50 | -1,062.50 | -1,187.50 | -1,062.50 | 125.00 |
EPS Diluted Continuous Ops | -1,032.77 | -1,034.77 | -924.98 | -1,037.59 | 104.14 |
EBITDA(a) | $-1,939 | $-1,829 | $1,735 | $-1,716 | $-1,477 |